Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia

Parkinson's Disease Clinical Trial

— Lab2Life  

Official title:

Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in PD Without Dementia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00917280
• Other study ID #: #E07-117
• Status: Completed
• Phase: N/A
• First received: June 8, 2009
• Last updated: June 1, 2015
• Start date: December 2008
• Est. completion date: July 2014

Study information

• Verified date: June 2015
• Source: Washington University School of Medicine
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The overall purpose of this research is to learn how Parkinson's disease affects thinking and memory in everyday life. Participation will involve thinking tests, questionnaires and interviews about thinking and activities in everyday life.

Description:

The overall purpose of this research is to learn how Parkinson's disease affects thinking and memory in everyday life. Participation will involve thinking tests, questionnaires and interviews about thinking and activities in everyday life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 174
• Est. completion date: July 2014
• Est. primary completion date: July 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 40 Years to 70 Years

Eligibility

Inclusion Criteria PD participants:

• WUSM Movement Disorders Clinic patients

• males or females between 40 and 70

• meet criteria for idiopathic typical PD

• classified at Hoehn & Yahr12 stage I, II, or III

• are currently treated with levodopa/carbidopa

Inclusion Criteria Control:

• The groups will be matched for age, education and gender

• No Parkinson Disease

Exclusion Criteria PD participants and Control:

• suspected dementia

• treatment with certain dopaminergic, anticholinergic or benzodiazepine medications

• other neurological problems

• brain surgery

• history or current psychotic disorder

• any condition which would interfere with testing

• control only: a biological family history of PD and being a caregiver or spouse of someone who has PD

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Parkinson Disease
• Parkinson's Disease

Locations

Country	Name	City	State
United States	Washington University School of Medicine	St. Louis	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
Washington University School of Medicine

Country where clinical trial is conducted

United States,